COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens

NACompletedINTERVENTIONAL
Enrollment

27,947

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

May 30, 2021

Study Completion Date

May 31, 2021

Conditions
SARS-CoV InfectionCovid19Coronavirus
Interventions
DIAGNOSTIC_TEST

Sequence of testing.

The participants will be tested in the following sequences of sampling technique: (1) nasopharyngeal swab, oropharyngeal swab, and salvia collection OR (2) oropharyngeal swab, salvia collection, and nasopharyngeal swab OR (3) salvia collection, nasopharyngeal swab, and oropharyngeal swab. Only the sequence is different in the different arm, while the sampling technique for each method is the same in all arms.

Trial Locations (1)

2500

Valby COVID-19 teststed, Copenhagen

All Listed Sponsors
collaborator

Hvidovre University Hospital

OTHER

collaborator

Region Hovedstadens Apotek

OTHER_GOV

lead

Rigshospitalet, Denmark

OTHER

NCT04715607 - COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens | Biotech Hunter | Biotech Hunter